可吸入的聚合物纳米颗粒含有三基化物修饰的声敏化剂,用于加强急性细菌性肺炎治疗
Lin Wang1,2, Fangzhou Chen1, Nier Wu1
1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 2, 2025
概括
这项研究引入了一种新型纳米粒子 (NPFCPS-P),将声动疗法 (SDT) 与三基化物结合起来,对抗多药耐药病原体产生强大的抗菌作用. 新的治疗方法在体外和体内都显示出高的疗效,为深层感染提供了抗生素的有希望的替代方案.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 传染性疾病 传染性疾病
背景情况:
- 声动力学疗法 (SDT) 对根深蒂固的感染有前景,但对抗多药耐药 (MDR) 细菌有困难.
- 将SDT与三基化物 (P+Ph3Br-) 结合起来,是克服MDR细菌耐药性的潜在策略.
研究的目的:
- 开发一种新型纳米粒子 (NPFCPS-P) 用于增强对MDR细菌的声动疗法.
- 为了研究SDT和P+Ph3Br-通过NPFCPS-P传递的协同抗菌作用.
- 评估NPFCPS-P加超声波 (美国) 在治疗细菌感染中的疗效和生物安全性.
主要方法:
- 伪结合聚合物PFCPS-P与声敏化剂 (FCPS) 和ROS敏感的硫基质键的制造,经P+Ph3Br-修改.
- 将PFCPS-P与DSPE-mPEG2000组合在一起,形成纳米粒子 (NPFCPS-P).
- 在实验室对MDR ESKAPE病原体进行检测,并在实体研究中使用小鼠Pseudomonas aeruginosa诱导的肺炎模型.
主要成果:
- NPFCPS-P加上美国在体外实现了>90%的MDR ESKAPE病原体的抑制.
- 治疗诱导了代谢障碍,抑制了核酸合成,破坏了能量代谢,增加了氧化应激,并抑制了细菌中的生物膜形成和毒性.
- 在体内,NPFCPS-P加上US在亚致命性肺炎中显示出99.3%的杀菌率,在致命性肺炎中显示出90%的存活率,加快肺损伤修复和抑制炎症反应.
结论:
- NPFCPS-P加上美国对MDR细菌表现出强大的协同抗菌活性.
- 开发的纳米粒子系统为治疗深层细菌感染提供了出色的生物安全性和治疗潜力.
- 这种方法代表了一种有希望的抗生素替代策略,用于对抗具有挑战性的细菌感染.
更多相关视频
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
10.7K
03:32A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
Published on: April 12, 2019
7.9K
相关概念视频
01:28Pneumonia IV: Management
313
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
01:30Pneumonia V: Nursing management and Prevention
1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
01:23Inhaled Medications
246
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
246
01:30Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
01:30Pneumonia I: Introduction
215
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
215
01:28Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174